Interventional, Randomised, Double-blind, Placebo-controlled, Fixed-dose Study of Vortioxetine in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Phase of Trial: Phase II
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Vortioxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 28 Oct 2016 Status changed from active, no longer recruiting to completed.
- 19 May 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Oct 2016.
- 19 May 2016 Status changed from recruiting to active, no longer recruiting.